基于目标的发现,一种广泛的流杀药
Daniel J Sprague1,2, Sang-Kyu Park1, Svenja Gramberg3
1Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.
Nature structural & molecular biology
|May 7, 2024
概括
一种新的药物 - - 米多奎那索林 (BZQ) - - 有效地向寄生虫平虫,包括对普拉齐素 (PZQ) 耐药的肝炎. 通过激活保存的离子通道,BZQ显示了针对多种虫物种的宽谱活性,提供了一个有前途的新型虫杀伤剂.
科学领域:
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
- 分子生物学分子生物学
背景情况:
- 寄生虫平虫感染导致全球重大健康问题.
- 普拉西昆 (PZQ) 是一种用于治疗杆菌病的初级治疗方法,但对Fasciola肝炎无效.
- 在Fasciola中对PZQ的耐药性与TRPMPZQ离子通道的突变有关.
研究的目的:
- 为了识别针对法西奥拉TRPMPZQ的新型活性化合物.
- 开发一种有效对抗抗 PZQ 抗性寄生虫的宽频流杀剂.
主要方法:
- 查本扎米多奎那索林类型对法西奥拉TRPMPZQ的检测.
- 结构-活性关系研究,以优化化合物.
- 对优化化合物的测试,针对各种寄生虫虫物种及其TRPMPZQ正义物种.
主要成果:
- 鉴定出本扎米多奎那索林类型对法西奥拉TRPMPZQ具有活性.
- 一个优化的连接体,BZQ,诱导了肝脏的和关损伤.
- BZQ对包括Schistosoma mansoni在内的多种虫物种表现出广泛的活性,并保留了TRPMPZQ的正义物种.
结论:
- BZQ 是一流的,广泛的杀菌剂.
- BZQ作为三极管TRPMPZQ的普遍激活剂.
- BZQ为寄生虫平虫感染提供了一个潜在的新疗法策略.
相关概念视频
Inhibitors of Bacterial DNA Synthesis
84
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
84
Anthelminthic Agents
83
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
83


